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Introduction
The innate immune response is the first line of defense
against pathogens. The response is non-specific in that patterns
rather than specific molecules, are detected. White blood cells,
including monocytes, express cell-surface proteins that detect
pathogens and initiate an immune response.
Toll-like receptors (TLRs) are a major group of pattern
recognition receptors (PRRs) expressed on the surface of a
variety of cells that function to recognize molecular patterns
associated with all classes of pathogenic microorganisms
(reviewed by Kawasaki et al., 2014). TLR4 specifically recognizes
the lipopolysaccharide (LPS) component of Gram-negative
bacterial cell walls.
Basigin (CD147) is a member of the immunoglobulin
superfamily (IgSF) that functions as a cell adhesion molecule. It
has been implicated in a variety of processes, including
reproduction and development, metabolism, and cancer
(reviewed by Muramatsu, 2016).
A recent study by this laboratory suggests that TLR4 and
Basigin interact via their transmembrane domains (Brown, 2016,
UNF Graduate thesis).
Studies of the neural retina indicate that Basigin gene
expression is linked to expression of Monocarboxylate
Transporter 1 (MCT1), which moves lactate, pyruvate, and ketone
bodies across the plasma membrane via facilitated diffusion
(Philp et al., 2003; Halestrap and Price, 1999). Basigin-null mice
do not express Basigin or MCT1 on photoreceptors or Müller
cells, which impairs delivery of metabolites from the Müller cells
to the photoreceptor cells (Philp et al., 2003). The result is
blindness in Basigin-null mice from the time of eye opening
(Ochrietor et al., 2002).
TLR4 has leucine-rich repeats in the extracellular 
domain, a single-pass transmembrane domain, 
and a toll-interferon receptor (TIR) domain in the 
cytoplasmic tail
Basigin (CD147) has two extracellular Ig 
domains, a single-pass transmembrane domain, 
and a short cytoplasmic tail
Wilson et al., 2002 Philp et al., 2003 Ochrietor et al., 2002
Purpose / Hypothesis
Two recent study by this laboratory showed that the
expression of Basigin and MCT1 transcripts is significantly
decreased in monocytes treated with LPS for 24 hours.
Expression of GLUT1 was also determined to not increase.
Because metabolic transporters do not increase in expression
in activated monocytes, the purpose of the present study was to
determine if those cells rely on substrates already found within
the cell by using the autophagy process. It was hypothesized
That proteins involved in autophagy would increase in expression
in response to exposure to LPS when compared to non-treated
conditions.
Methodology
RAW 264.7 monocytes were grown at 37oC in 5% CO2 in
RPMI 1640 medium (Gibco – Life Technologies, Grand Island,
NY) containing 10% FBS (HyClone, GE Healthcare-BioSciences,
Marlborough, MA).
RAW 264.7 cells were plated in serum-free RPMI 1640
medium (Gibco – Life Technologies) and allowed to attach.
The cells were treated with LPS (1 µg/mL; InvivoGen, San
Diego, CA) or Dulbecco’s phosphate buffered saline (D-PBS;
Gibco – Life Technologies) for 24 hours at 37oC in 5% CO2.
Cells were harvested and detergent protein lysates were
generated (Philp et al., 2003).
APG-1, APG16L, BECN1, and Rab24 protein expression was
determined by a direct ELISA using antibodies specific for each
protein (Abgent Antibodies, San Diego, CA). Expression within
LPS treated cells and D-PBS-treated cells were analyzed using
one-way ANOVA and post one-way T Test.
Figure 1. Expression of APG-1 is not increased in monocytes in
response to LPS treatment. The absorbance at 405 nm
corresponds to the expression of APG-1 in RAW 264.7
monocytes. The values represent the average of two runs and
the error bars represent the standard deviation. p=0.369 via a
paired, one-tailed T-test.
Figure 2. Expression of APG16L is not increased in monocytes in
response to LPS treatment. The absorbance at 405 nm
corresponds to the expression of APG16L in RAW 264.7
monocytes. The values represent the average of two runs and
the error bars represent the standard deviation. p=0.157 via a
paired, one-tailed T-test.
Figure 3. Expression of BECN1 is not increased in monocytes in
response to LPS treatment. The absorbance at 405 nm
corresponds to the expression of BECN1 in RAW 264.7
monocytes. The values represent the average of two runs and
the error bars represent the standard deviation. p=0.238 via a
paired, one-tailed T-test.
Results
Proteins at different phases of the autophagy pathway were
tested so that the full process could be evaluated (Kroemer and
Levine, 2008). The protein APG-1 is used to initiate the process.
The APG16L protein is used in autophagy vesicle formation. The
BECN1 protein regulates endolytic processing in the late stages
of autophagy. The Rab24 protein is a G-protein that is expressed
during the formation and regulation of autophagic vacuoles.
The expression of the autophagy proteins APG-1, APG16L,
BECN1, and Rab24 within RAW 264.7 monocytes were
determined to not be upregulated in response to treatment with
LPS. This suggests that autophagy is not used as a means of
obtaining metabolic substrates during an immune response.
Future studies will continue to assess the shift in metabolism
observed in monocytes during an immune response to determine
what substrates other than monocarboxylates are used.
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Expression of Basigin (A) and MCT1 (B) transcripts in RAW 264.7 cells.
The open bars represent D-PBS-treatment and the gray bars represent 
LPS-treatment. The error bars represent the Coefficient of Variation. 
*=p<0.05 via T-test 
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Autophagy  is a tightly 
regulated process in 
which a vesicle forms 
to consume 
intracellular resources.  
The regulatory point of 
each protein tested is 
shown. © 2009 Alicia Meléndez and Beth Levine
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Figure 3. Expression of BECN1 is not increased in monocytes in
response to LPS treatment. The absorbance at 405 nm
corresponds to the expression of BECN1 in RAW 264.7
monocytes. The values represent the average of two runs and
the error bars represent the standard deviation. p=0.152 via a
paired, one-tailed T-test.
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